MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

256.46 -3.75 (-1.44%)
Official Closing Price Updated: 7:00 PM EDT, Sep 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,729,804
Open 257.96
Bid (Size) 256.00 (100)
Ask (Size) 256.58 (500)
Prev. Close 260.21
Today's Range 255.58 - 258.91
52wk Range 190.75 - 267.47
Shares Outstanding N/A
Dividend Yield 2.70%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Dividend Stocks to Buy and Hold Forever (Including 1 Dividend King) ↗
Owning these dividend stocks could be a simple way to make money over the long term. 
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? ↗
AbbVie's immunology pivot is offsetting Humira's decline, while Pfizer trades at half the valuation despite patent risks ahead. 
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
+11.8%
+11.8%
1 Month
+4.2%
+4.2%
3 Month
+12.9%
+12.9%
6 Month
+11.5%
+11.5%
1 Year
+20.4%
+20.4%

More News

Read More
News headline image
True Beauty Aesthetics Marks One-Year Milestone With Open House
Via Press Advantage
News headline image
AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
If You Invested $100 In AbbVie Stock 10 Years Ago, You Would Have This Much Today ↗
Via Benzinga
News headline image
Billionaire Ken Griffin Increased His Stake in This Dividend King by 547% in Q2. Wall Street Thinks It's Still a Buy. ↗
Via The Motley Fool
News headline image
2 S&P 500 Stocks with Exciting Potential and 1 We Brush Off
Via StockStory
Topics Electric Vehicles Stocks World Trade
News headline image
Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead. ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Dividend Stocks to Buy and Never Sell ↗
Via The Motley Fool
Topics Economy
News headline image
The Dividend ETF That Generates Passive Income While You Sleep ↗
Via The Motley Fool
Topics ETFs
News headline image
3 Unpopular Stocks That Deserve Some Love
Via StockStory
Topics Energy
News headline image
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead ↗
Via The Motley Fool
News headline image
Plastic Surgeon Dr. Young Cho Named to National MD Codes Faculty
Via Press Advantage
News headline image
Billionaire Ken Griffin Increased His Position in This Dividend King by 547% ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
From Equity Insider
Via GlobeNewswire
News headline image
2 Dividend Stocks That Are No-Brainer Buys in August ↗
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
Neuroscience Is Becoming AbbVie's Quiet Powerhouse -- and Management Now Sees $12.7 Billion in Sales This Year ↗
Via The Motley Fool
News headline image
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More ↗
Via The Motley Fool
News headline image
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
From USA News Group
Via GlobeNewswire
News headline image
2 Reasons to Like ABBV and 1 to Stay Skeptical
Via StockStory
Topics Stocks Supply Chain
News headline image
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026? ↗
Via The Motley Fool
Topics Stocks
News headline image
AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry? ↗
Via The Motley Fool

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 256.46
When was AbbVie last traded?
The last trade of AbbVie was at 09/04/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story